Analyst Ratings for Pacira Pharmaceuticals (PCRX)
PCRX Rating Summary
PCRX Price Target Summary
- Highest: $38.00 (H.C. Wainwright)
- Lowest: $24.00 (RBC Capital)
- Average: $29.20
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$29.20 (+30.8%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
Avg. $ Target:
$29.20 (+30.8%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2025 | Barclays » Updated 3/26/2026 |
Jenna Davidner | New Coverage | Equalweight (N/A) |
25.00 (27.00) |
23.99 (22.33) |
-6.92% | Details |
| 11/17/2025 | H.C. Wainwright | Douglas Tsao | New Coverage | Buy (N/A) |
38.00 (N/A) |
23.78 (22.33) |
-6.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
